shutterstock_501493168_photolona

photolona / Shutterstock.com

19 January 2023GenericsLiz Hockley

Jazz Pharma’s medical cannabis unit seeks to block generic

UK-based cannabidiol lab sues firms behind proposed ANDA | Feud centres on a cannabis treatment for epilepsy.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

English High Court denies Jazz units’ jurisdictional challenge

4 May 2022 Two subsidiaries of Ireland-based Jazz Pharmaceuticals have failed in their bid to challenge the jurisdiction of the English High Court in a dispute with Tokyo-headquartered Otsuka Pharmaceutical over a cannabis sativa collaboration.

Jazz Pharmaceuticals acquires UK medical cannabis firm for $7.2bn

4 February 2021 Jazz Pharmaceuticals has acquired UK medicinal cannabis company GW Pharmaceuticals in a takeover worth $7.2 billion.

Jazz Pharma loses patent case over narcolepsy drug

28 February 2023 Court finds no method-of-use in patent claims | Judgment is a win for rival firm Avadel.

More on this story

English High Court denies Jazz units’ jurisdictional challenge

4 May 2022 Two subsidiaries of Ireland-based Jazz Pharmaceuticals have failed in their bid to challenge the jurisdiction of the English High Court in a dispute with Tokyo-headquartered Otsuka Pharmaceutical over a cannabis sativa collaboration.

Jazz Pharmaceuticals acquires UK medical cannabis firm for $7.2bn

4 February 2021 Jazz Pharmaceuticals has acquired UK medicinal cannabis company GW Pharmaceuticals in a takeover worth $7.2 billion.

Jazz Pharma loses patent case over narcolepsy drug

28 February 2023 Court finds no method-of-use in patent claims | Judgment is a win for rival firm Avadel.

More on this story

English High Court denies Jazz units’ jurisdictional challenge

4 May 2022 Two subsidiaries of Ireland-based Jazz Pharmaceuticals have failed in their bid to challenge the jurisdiction of the English High Court in a dispute with Tokyo-headquartered Otsuka Pharmaceutical over a cannabis sativa collaboration.

Jazz Pharmaceuticals acquires UK medical cannabis firm for $7.2bn

4 February 2021 Jazz Pharmaceuticals has acquired UK medicinal cannabis company GW Pharmaceuticals in a takeover worth $7.2 billion.

Jazz Pharma loses patent case over narcolepsy drug

28 February 2023 Court finds no method-of-use in patent claims | Judgment is a win for rival firm Avadel.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB

Lewis Roca promotes tech expert to managing partner

Panitch Schwarze brings in molecular biologist

US targets ‘product hopping’ with biologic litigation curbs

UPC confirms validity of Edwards Lifesciences heart valve tech patent

ITC concludes row over biotech lab equipment between US and German rivals

UKIPO launches ‘revolutionary’ patent filing and AI tool

USPTO clarifies AI's role in patent eligibility